Get the app Watchlists Portfolios Alerts Sign in Get started

Menu

Defiance Autism Impact ETF ASD

Full chart Compare

Set alert

27.26 USD -0.28 (-1.02%)

At closeNov 3, 2026, 4:00 PM EST

27.21 -0.05 -0.19%

After hours · Nov 3, 4:00 PM ET

27.26 Day range 27.32

24.59 52-week range 28.52

YTD: +10.72%
1 year: +10.72%

Issuer: Defiance
Asset class: Equity
Expense ratio: 0.79%
Assets under management: $1.37M
NAV: 27.38
Holdings: 40
Inception: 2026-06-01
Top 10 weight: 31.62%

RVTY Revvity Inc 3.44%
LLY Eli Lilly & Co 3.31%
HLUN-B.CO H Lundbeck A/S 3.15%
4506.T Sumitomo Pharma Co Ltd 3.15%
MCOV-B.ST Medicover AB 3.14%
NOVN.SW Novartis AG 3.13%
4502.T Takeda Pharmaceutical Co Ltd 3.09%
ROP.SW Roche Holding AG 3.08%
BTSG BrightSpring Health Services Inc 3.07%
ABBV AbbVie Inc 3.06%
TEVA.TA Teva Pharmaceutical Industries Ltd 2.96%
PSON.L Pearson PLC 2.95%
PFE Pfizer Inc 2.93%
RGEN Repligen Corp 2.84%
4507.T Shionogi & Co Ltd 2.79%
ACHC Acadia Healthcare Co Inc 2.79%
4578.T Otsuka Holdings Co Ltd 2.79%
GSK.L GSK PLC 2.75%
LFST LifeStance Health Group Inc 2.74%
GHC Graham Holdings Co 2.73%
JNJ Johnson & Johnson 2.71%
LHC.JO Life Healthcare Group Holdings Ltd 2.70%
KPJ Healthcare Bhd 2.63%
NEU.AX Neuren Pharmaceuticals Ltd 2.63%
BMY Bristol-Myers Squibb Co 2.60%

Healthcare 86.55%
Consumer Defensive 5.18%
Communication Services 2.87%
Industrials 2.72%
Consumer Cyclical 2.68%

United States 58.16%
Japan 11.72%
Switzerland 5.96%
United Kingdom 5.47%
Israel 5.09%
Denmark 3.05%
Sweden 3.00%
South Africa 2.66%
France 2.47%
Malaysia 2.43%

Updated 2026-11-03